Mécanisme d'inhibition de la fusion membranaire du virus de l'hépatite C par différents composés : l'arbidol, la silymarine et les molécules la composant

Mécanisme d'inhibition de la fusion membranaire du virus de l'hépatite C par différents composés : l'arbidol, la silymarine et les molécules la composant

L'infection par le virus de l'hépatite C (VHC) est un problème de santé publique majeur car en absence de vaccin et de thérapie suffisamment efficace, l’infection peut dégénérer en carcinome hépatocellulaire. Il est alors important d’identifier de nouvelles cibles thérapeutiques et de déve...

Full description

Bibliographic Details
Main Author:	Boutin, Elodie
Other Authors:	Lyon 1
Language:	fr en
Published:	2010
Subjects:	Virus de l'hépatite C Antiviral Entrée cellulaire Fusion membranaire Arbidol Silymarine Silibinine Spectroscopie de fluorescence RMN Résonance plasmonique de surface Microscopie Hepatitis C virus Cell entry Membrane fusion Silymarin Silibinin Fluorescence spectroscopy NMR Surface plasmon resonance Microscopy 572
Online Access:	http://www.theses.fr/2010LYO10244

Similar Items

Étude des mécanismes moléculaires des inhibiteurs de l'entrée du virus de l'hépatite C (HCV) Silibinine et Arbidol : microenvironnement hépatique et infection par le HCV
by: Blaising, Julie Élisabeth Françoise
Published: (2013)

BENEFICIAL EFFECTS OF SILYMARIN AGAINST NEPHROTOXICITY CAUSED BY SOME CHEMICALS
by: V. Ivanov, et al.
Published: (2021-06-01)

The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
by: Momir Mikov, et al.
Published: (2011-10-01)

VIRUS-SPECIFIC THERAPY OF INFLUENZA, HISTORY AND MODERN STATE
by: I. A. Leneva
Published: (2017-11-01)

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
by: Jan Haviernik, et al.
Published: (2018-04-01)

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
by: Marzieh Nojomi, et al.
Published: (2020-12-01)

Isolation of Active Substances from the Seeds of the Milk Thistle Plant (Silybum marianum) and Determination of Antioxidant Activity
by: Bušić, V., et al.
Published: (2011-09-01)

Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
by: Peng Yin, et al.
Published: (2021-07-01)

A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties
by: Valeria Romanucci, et al.
Published: (2018-12-01)

Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
by: Maryam Fallah, et al.
Published: (2021-10-01)

Pharmacokinetics of pure silybin diastereoisomers and identification of their metabolites in rat plasma
by: Petr Marhol, et al.
Published: (2015-04-01)

Pharmacological and Epidemiological Study of the Course of Influenza and Other ARVI in the Season 2010/11 in Children under the Age of 18
by: V. F. Uchaikin, et al.
Published: (2016-04-01)

The Range of Application of Domestic Antiviral Drug in Рediatrics
by: O. V. Shamsheva, et al.
Published: (2015-12-01)

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
by: Hailong Li, et al.
Published: (2021-01-01)

Preparation and evaluation of taste masked oral suspension of arbidol hydrochloride
by: Ling Wang, et al.
Published: (2015-02-01)

Application of domestic anti-viral drug in pediatric practice
by: V. A. Bulgakova, et al.
Published: (2016-04-01)

Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
by: Peter F. Surai
Published: (2015-03-01)

Lung Cancer Management with Silibinin: A Historical and Translational Perspective
by: Sara Verdura, et al.
Published: (2021-06-01)

cis–trans Isomerization of silybins A and B
by: Michaela Novotná, et al.
Published: (2014-05-01)

Improving the Solubilization and Bioavailability of Arbidol Hydrochloride by the Preparation of Binary and Ternary β-Cyclodextrin Complexes with Poloxamer 188
by: Md. Khalid Anwer, et al.
Published: (2021-04-01)

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
by: Chunguang Yang, et al.
Published: (2020-05-01)

Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)
by: N Yu Pshenichnaya, et al.
Published: (2019-03-01)

Antiviral Activities of Silymarin and Derivatives
by: Ching-Hsuan Liu, et al.
Published: (2019-04-01)

Comparative efficacy and safety of preventive treatment with cytovir-3 and arbidol in children during seasonal outbreak of respiratory viral infection (an open-label randomized clinical study)
by: V. S. Smirnov, et al.
Published: (2019-07-01)

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
by: Jie Fang, et al.
Published: (2020-09-01)

Étude des propriétés antivirales de composés originaux dans le cadre du développement de nouvelles thérapies contre le virus de l'Hépatite C
by: Alotte, Christine
Published: (2010)

Efficacy of ingavirin in influenza treatment in adults
by: L V Kolobukhina, et al.
Published: (2009-03-01)

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: O N Titova, et al.
Published: (2018-08-01)

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: O.N. Titova, et al.
Published: (2018-08-01)

Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series
by: Wei Gao, et al.
Published: (2020-10-01)

Crystal Structures, Thermal Analysis, and Dissolution Behavior of New Solid Forms of the Antiviral Drug Arbidol with Dicarboxylic Acids
by: Alex N. Manin, et al.
Published: (2015-12-01)

Atividades antimutagênica, antigenotóxica e anticitotóxica de Silybum marianum (L.) Gaertn e sua influência na expressão de genes de resposta a danos no DNA
by: Borges, Flavio Fernandes Veloso
Published: (2016)

Time course of changes in cytokines (IFN-γ, IFN-α, IL-18, TNF-α) in the treatment of moderate influenza A (H1N1) pdm09 (2013-2016) with oseltamivir (Tamiflu) and umifenovir (Arbidol) alone and in combination with Kagocel
by: A F Popov, et al.
Published: (2017-10-01)

The use of Different Schemes of Antiviral Therapy of Acute Respiratory Viral Infection in Children
by: A. L. Zaplatnikov, et al.
Published: (2015-10-01)

Prevention and Treatment of Frequent Respiratory Diseases in Children With Weakened Immune Systems
by: O. V. Kladova
Published: (2016-04-01)

Clinical and Laboratory Characteristics of Viral Diarrhea in Children and Antiviral Therapy
by: E. V. Mikhailova, et al.
Published: (2016-04-01)

Développement d'une nouvelle famille d'inhibiteurs de cyclophilines à large spectre antiviral et étude de leurs mécanismes d'action dans les infections par le Virus de l'Hépatite C et les Coronavirus.
by: Nevers, Quentin
Published: (2018)

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial
by: Chang Chen, et al.
Published: (2021-09-01)

Entrée de la protéine de la capside du virus de l'hépatite C dans les cellules humaines
by: Ouellet, Dominique
Published: (2004)

Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
by: H.B. Li, et al.
Published: (2015-05-01)

Cannot write session to /tmp/vufind_sessions/sess_jsp9nffbvu9utfjbrtrlu4qgbq